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The  human  gut  symbiont  Lactobacillus  reuteri  produces  and  secretes  reuterin,  as  an intermediate  in  the reduction of glycerol  to 1,3‐propanediol. Reuterin  formation could be a tool for Lactobacillus reuteri to outcompete other species, first because it’s a strong antimicrobial  agent  against  pathogens  and  the  commensal  gut  bacteria  but  secondly, because it is an electron acceptor in the anaerobic environment of the gut. In our study on  glycerol  fermentation  by  human  faecal  microbiota  we  found  that  rapid  glycerol fermenting communities exhibited shifts in their Lactobacillus‐Enterococcus community (De Weirdt et  al.,  2010). Based on  in  vitro  13C‐glycerol batch  fermentations by human faecal  microbiota,  we  suggested  that  within  this  community,  glycerol‐degrading lactobacilli  were  responsible  for  the  rapid  reduction  of  glycerol  to  1,3‐propanediol because  these  lactobacilli  were  most  efficiently  producing  reuterin  as  an  electron accepting  intermediate.  Reuterin  is  a  very  reactive molecule  (the  core molecule  is  an aldehyde)  and  can  be  dehydrated  to  acrolein,  which  is  a  highly  reactive  toxin  that rapidly binds to the antioxidant glutathione and has a mutagenic potency comparable to formaldehyde. Therefore,  it  is desirable  to assess  the physiological effects of microbial reuterin  formation  on  gut  epithelial  cells.  Using  confluent  2‐D  cultures  of  colon carcinoma Caco‐2 cells, we found evidence for a potential reuterin effect on cell viability and  metabolic  activity.  However,  the  effects  were  very  variable  and  seemed  to  be connected with  the  physiological  state  of  the  cancer  cells  (e.g.  differentiation  status). Furthermore,  100 µM reuterin  affected  single  colon  carcinoma  cells  (HT‐29  and HCT‐116), but didn’t affect their 3‐D aggregates. We are currently investigating the reuterin effects  more  closely  in  a  fully  developed  3‐D  model  of  intestinal  epithelium,  which mimics the parental tissue in vivo (Barilla et al., 2010). In addition, the effect of reuterin production on infection by Salmonella enterica serovar Typhimurium is being examined.  Overall, we hypothesized that in situ reuterin production by Lactobacillus reuteri will not affect  the  healthy  gut  epithelial  tissue  negatively,  while  actively  protecting  the  cells against enteric infection.   
